Vilon
Moderate ResearchDipeptide bioregulator
Vilon (Lys-Glu) is a dipeptide bioregulator that has been studied in immunology research for its effects on immune cell function and gene expression modulation. Published research has investigated its role in thymic function and its effects on lymphocyte activity. RaysunPeptide supplies Vilon for qualified research and laboratory applications.
Mechanism of Action
Vilon works through epigenetic modulation, restoring chromatin structure and gene expression in immune cells. It stimulates thymocyte proliferation, activates T-helper cells, and increases the proliferative index in thymus tissue (from 26% to 37% in studies). The peptide modulates tyrosine phosphorylation of mitogen-activated cytoplasmic kinases and helps rejuvenate aged immune systems by restoring proper gene expression patterns.
Key Benefits
Molecular Data
Dosing Protocols
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Standard protocol | 10-20 mg | Daily for 10-20 days | Oral capsules |
| Maintenance | 10 mg | 2-3 cycles yearly | Oral capsules |
Research Indications
Immune Support
Stimulates thymocyte proliferation and enlarges thymic lobules.
Activates T-helper cells and improves immune response.
Restores chromatin structure and gene expression in aged lymphocytes.
Anti-Aging
Long-term treatment increased mean lifespan 20-40% in rodent studies.
Suppresses development of spontaneous and induced tumors.
Promotes recovery in tissues exposed to radiation damage.
GI Health
Restores brush border membrane enzyme levels in aged animals.
Enhances intestinal barrier function in aged rats.
Peptide Interactions
Both target thymus/immune system; complementary mechanisms.
Often combined in comprehensive anti-aging Khavinson protocols.
Both have immunoprotecting properties; different mechanisms.
Related immune peptides; can be used in comprehensive protocols.
What to Expect
Side Effects & Safety
Common (Generally Mild)
- •Generally well-tolerated
- •Minimal side effects reported
Stop Signs (Seek Medical Attention)
- ⚠Allergic reactions
- ⚠Unusual immune symptoms
Contraindications
- ✕Active autoimmune flares (consult physician)
- ✕Known hypersensitivity
- ✕Pregnancy or breastfeeding
Quality Checklist
Good Signs ✓
- White powder or capsules
- Clear solution if reconstituted
- Proper packaging and labeling
Warning Signs !
- Unknown source or purity
Bad Signs ✕
- Discoloration
- Unusual odor
- Damaged packaging
References
Long-term treatment with peptide preparations including Vilon increased mean lifespan 20-40% and suppressed tumorigenesis.
Vilon improved lymphocytes from old people by restoring chromatin structure and gene expression.
Vilon and other Khavinson peptides modulate key proliferative patterns and tyrosine phosphorylation of kinases.
Vilon and related peptides possess age-associated immunoprotecting properties in the spleen.
FAQs
How significant is the 20-40% lifespan extension from Vilon - is it proven in humans?
Animal studies showed 20-40% mean lifespan increases with long-term Vilon treatment plus tumor suppression. These are compelling preclinical findings but haven't been replicated in human longevity trials - lifespan extension is theorized based on mechanisms and animal models rather than clinical proof. Effects in humans are likely more modest.
Can Vilon be used continuously or must it follow the 10-20 day cycling protocol?
Vilon follows Khavinson bioregulator cycling: 10-20 days on, then off, repeated 2-3 times yearly. Cycling allows the body's natural feedback mechanisms to maintain homeostasis and prevents tolerance. Continuous use isn't recommended and may blunt epigenetic effects through feedback inhibition.
Does Vilon improve intestinal health and can it help with digestive issues?
Yes, Vilon restores brush border membrane enzyme levels and enhances intestinal barrier function in aged animals. This suggests potential benefits for age-related digestive decline and GI barrier integrity. However, direct clinical data for specific digestive conditions is limited - benefits are inferred from mechanisms.
Is Vilon the shortest bioregulator peptide and does size matter for absorption?
Yes, Vilon is the shortest Khavinson peptide at just 2 amino acids, giving it excellent oral absorption. The dipeptide size allows convenient capsule administration with good GI bioavailability - making it more practical than longer peptide bioregulators requiring injection.
